belumosudil (KD025 ) - Kadmon, Romeck Pharma
KD025: Patent expiry in 2035 (Kadmon, 22nd Annual H.C. Wainwright Global Investment Conference 2020 (Virtual Meeting)) Sep 15, 2020 
Patent Graft versus Host Disease • Idiopathic Pulmonary Fibrosis • Psoriasis
https://wsw.com/webcast/hcw7/kdmn/1600890
 
Sep 15, 2020
 
 
51153279-d66a-46ba-aa26-f8ef5cf929ba.jpg